Home
News
Create
Screeners
Insights
Genpharmasec
1.
08
+0.15
(+16.13%)
Market Cap
₹59.81 Cr
PE Ratio
-46.50
Industry
Commercial Services
Buy
Sell
Company Performance:
1D
+16.13%
1M
-8.47%
6M
-42.86%
1Y
-43.16%
5Y
-78.78%
View Company Insights
Latest news about Genpharmasec
Genpharmasec Limited Conducts Independent Directors Meeting on March 24, 2026
10 days ago
Genpharmasec Limited held its mandatory separate meeting of independent directors on March 24, 2026, lasting 30 minutes from 11:00 A.M. to 11:30 A.M. The meeting addressed three key governance areas: reviewing performance of non-independent directors and the board, assessing the chairperson's performance with input from executive and non-executive directors, and evaluating information flow quality between management and the board. The session was conducted in compliance with Companies Act 2013 and SEBI LODR Regulations 2015, with the outcome officially communicated to BSE Limited through proper documentation signed by Independent Director Mr. Siddhesh Shende.
Genpharmasec Limited Reports Q3FY26 Results with Strong Standalone Revenue Growth
Feb 09, 2026
Genpharmasec Limited Reports Strong Q1 Results with 128% Revenue Growth
Aug 07, 2025
Genpharmasec Completes 70% Acquisition of Derren Healthcare for INR 34.15 Crores
Jul 25, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO